Baday, Murat, Calamak, Semih, Durmus, Naside Gozde et al. · Small (Weinheim an der Bergstrasse, Germany) · 2016 · DOI
Researchers developed a new technology that uses smartphones and magnetic fields to analyze blood cells without needing special dyes or labels. The system can identify and count white and red blood cells quickly and affordably, and it works in clinics, hospitals, and homes. This portable device could help doctors monitor patients with rare diseases, including ME/CFS, more easily and at lower cost.
For ME/CFS patients and researchers, accessible point-of-care blood analysis tools could enable frequent, affordable monitoring of immune cell abnormalities and other hematologic markers implicated in ME/CFS pathophysiology. The portability and low cost of i-LEV could facilitate distributed research and home-based patient monitoring, addressing barriers to longitudinal biomarker tracking in this understudied rare disease.
This study does not demonstrate that i-LEV can detect ME/CFS-specific biomarkers or that it performs equivalently to clinical laboratory hematology analyzers. The abstract does not report clinical validation data, comparison with gold-standard methods, or application to any patient populations. This is a technology development study, not a clinical diagnostic study.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →